Digital x-ray developer Nanox produced over $2 million in revenue the second quarter of 2022, although its net loss also rose considerably over the same period in 2021.
For the second quarter (end-June 30), Nanox had revenue of $2.2 million, compared with no revenue during the same period in 2021 and $1.8 million in the first quarter of 2022. Revenues were generated through the sales of radiology services and artificial intelligence (AI) platforms, according to the vendor.
Nanox had a net loss of $19.6 million, compared with a net loss of $13.6 million in the same period last year. The company attributed the higher loss largely to expenses related to the acquisition of the MDWeb market platform, the consolidation of Nanox.AI and USARad, and increases in the company's research and development expenses, goodwill impairment, and general and administrative expenses.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
